Latest news with #SinengElectricLtd
Yahoo
2 days ago
- Business
- Yahoo
Asian Growth Companies With Strong Insider Ownership August 2025
As global markets experience significant shifts, with the Nasdaq Composite reaching new heights and China's exports showing resilience despite trade tensions, investors are increasingly focusing on growth opportunities in Asia. In this environment, companies with strong insider ownership can be particularly appealing as they often indicate a high level of confidence from those who know the business best. Top 10 Growth Companies With High Insider Ownership In Asia Name Insider Ownership Earnings Growth Zhejiang Leapmotor Technology (SEHK:9863) 15.6% 61% Vuno (KOSDAQ:A338220) 15.6% 109.8% Sineng ElectricLtd (SZSE:300827) 36% 25.8% Shanghai Huace Navigation Technology (SZSE:300627) 24.3% 23.9% Samyang Foods (KOSE:A003230) 11.7% 27.2% Oscotec (KOSDAQ:A039200) 12.7% 98.7% Novoray (SHSE:688300) 23.6% 28.2% Laopu Gold (SEHK:6181) 35.5% 43% Gold Circuit Electronics (TWSE:2368) 31.4% 31.8% Fulin Precision (SZSE:300432) 12.8% 43.7% Click here to see the full list of 588 stocks from our Fast Growing Asian Companies With High Insider Ownership screener. Let's review some notable picks from our screened stocks. CLASSYS Simply Wall St Growth Rating: ★★★★★★ Overview: CLASSYS Inc. is a global provider of medical aesthetics devices with a market cap of ₩3.90 trillion. Operations: The company generates its revenue primarily from the Surgical & Medical Equipment segment, which amounts to ₩269.67 billion. Insider Ownership: 13.6% CLASSYS is trading at 37.3% below its estimated fair value, with revenue and earnings forecast to grow significantly above the market averages. Despite no recent insider trading activity, the company's high insider ownership aligns management interests with shareholders. Recent earnings showed robust growth, with sales increasing to KRW 77.10 billion in Q1 2025 from KRW 50.40 billion a year ago, indicating strong operational performance amidst ongoing strategic presentations across Asia. Click to explore a detailed breakdown of our findings in CLASSYS' earnings growth report. The analysis detailed in our CLASSYS valuation report hints at an deflated share price compared to its estimated value. OSL Group Simply Wall St Growth Rating: ★★★★★☆ Overview: OSL Group Limited is an investment holding company that operates in the digital assets and blockchain platform sector across Hong Kong, Australia, Japan, Singapore, and Mainland China with a market cap of HK$11.65 billion. Operations: The company's revenue segment includes HK$374.75 million from its digital assets and blockchain platform business. Insider Ownership: 29.1% OSL Group's high insider ownership is complemented by substantial recent insider buying, aligning management interests with shareholders. The company forecasts significant revenue and earnings growth, outpacing Hong Kong market averages. Despite recent shareholder dilution, OSL became profitable this year and anticipates a 48.4% annual profit increase. Recent strategic moves include a HK$1.51 billion follow-on equity offering and collaboration with MoneyHero to enhance digital asset offerings in Hong Kong, reflecting its dynamic growth strategy amidst board changes. Click here and access our complete growth analysis report to understand the dynamics of OSL Group. In light of our recent valuation report, it seems possible that OSL Group is trading beyond its estimated value. Chenbro Micom Simply Wall St Growth Rating: ★★★★★★ Overview: Chenbro Micom Co., Ltd. is involved in the R&D, design, manufacture, processing, and trading of computer peripherals and systems globally, with a market cap of NT$70.54 billion. Operations: The company's revenue primarily comes from its computer peripherals segment, which generated NT$15.90 billion. Insider Ownership: 24.9% Chenbro Micom's high insider ownership aligns with its strategic focus on growth, as evidenced by a forecasted revenue increase of 25.7% annually, surpassing the Taiwan market average. Despite recent share price volatility, Chenbro showcases robust R&D capabilities and manufacturing strength at COMPUTEX 2025, emphasizing AI server solutions and collaborations with major tech firms like NVIDIA. Recent dividend announcements further highlight its commitment to shareholder value amidst evolving global enterprise demands. Dive into the specifics of Chenbro Micom here with our thorough growth forecast report. Our valuation report unveils the possibility Chenbro Micom's shares may be trading at a premium. Where To Now? Click through to start exploring the rest of the 585 Fast Growing Asian Companies With High Insider Ownership now. Seeking Other Investments? AI is about to change healthcare. These 24 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include KOSDAQ:A214150 SEHK:863 and TWSE:8210. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 days ago
- Business
- Yahoo
3 Asian Growth Companies With High Insider Ownership Growing Revenues At 10%
As global markets grapple with renewed trade tensions and economic uncertainties, the Asian market is navigating a complex landscape marked by both challenges and opportunities. In this environment, companies exhibiting strong revenue growth and high insider ownership can be particularly appealing to investors seeking stability and alignment of interests. Top 10 Growth Companies With High Insider Ownership In Asia Name Insider Ownership Earnings Growth Vuno (KOSDAQ:A338220) 15.6% 109.8% Suzhou Sunmun Technology (SZSE:300522) 35.4% 77.7% Sineng ElectricLtd (SZSE:300827) 36% 25.8% Samyang Foods (KOSE:A003230) 11.7% 27.2% Oscotec (KOSDAQ:A039200) 12.7% 98.7% Novoray (SHSE:688300) 23.6% 28.2% M31 Technology (TPEX:6643) 30.8% 63.4% Laopu Gold (SEHK:6181) 35.5% 43% Gold Circuit Electronics (TWSE:2368) 31.4% 26.5% Fulin Precision (SZSE:300432) 13.6% 43.7% Click here to see the full list of 587 stocks from our Fast Growing Asian Companies With High Insider Ownership screener. Below we spotlight a couple of our favorites from our exclusive screener. Shanghai Liangxin ElectricalLTD Simply Wall St Growth Rating: ★★★★☆☆ Overview: Shanghai Liangxin Electrical Co., Ltd. engages in the research, development, production, and sale of low-voltage electrical apparatus both in China and internationally with a market cap of CN¥10.88 billion. Operations: Shanghai Liangxin Electrical Co., Ltd. generates its revenue through the research, development, production, and sale of low-voltage electrical apparatus in domestic and international markets. Insider Ownership: 30.4% Revenue Growth Forecast: 18.2% p.a. Shanghai Liangxin ElectricalLTD is positioned for significant earnings growth, with forecasts indicating a 27.6% annual increase over the next three years, outpacing the broader Chinese market. Despite a decline in profit margins from 11.2% to 7.4%, the company trades at a considerable discount to its estimated fair value. Revenue growth is projected at 18.2% annually, surpassing market averages but remaining below high-growth thresholds, while insider ownership remains stable without recent trading activity. Click here and access our complete growth analysis report to understand the dynamics of Shanghai Liangxin ElectricalLTD. Our valuation report here indicates Shanghai Liangxin ElectricalLTD may be undervalued. Kyland Technology Simply Wall St Growth Rating: ★★★★★☆ Overview: Kyland Technology Co., Ltd. specializes in industrial Ethernet technology both in China and internationally, with a market cap of CN¥13.92 billion. Operations: Kyland Technology's revenue is primarily derived from its Industrial Internet and Related Businesses segment, which generated CN¥1.03 billion. Insider Ownership: 15.3% Revenue Growth Forecast: 23.8% p.a. Kyland Technology is poised for substantial growth, with earnings expected to increase by 37.89% annually over the next three years, outstripping the broader Chinese market's growth. Revenue is also set to rise significantly at 23.8% per year. However, profit margins have declined from 18.5% to 7.5%, and its forecasted Return on Equity remains low at 6.7%. Recent shareholder meetings indicate potential changes in project funding strategies, but no insider trading activity has been reported recently. Dive into the specifics of Kyland Technology here with our thorough growth forecast report. Our valuation report here indicates Kyland Technology may be overvalued. Lifedrink Company Simply Wall St Growth Rating: ★★★★☆☆ Overview: Lifedrink Company, Inc. manufactures and sells soft drinks in Japan with a market cap of ¥122.39 billion. Operations: Revenue segments for the company include the manufacture and sale of soft drinks in Japan. Insider Ownership: 12.3% Revenue Growth Forecast: 10.7% p.a. Lifedrink Company is experiencing moderate growth, with earnings projected to rise by 12.69% annually, surpassing Japan's market average of 8%. Revenue is expected to grow at 10.7% per year, outpacing the broader market but not reaching high-growth thresholds. Insider ownership remains strong, and recent corporate actions include a JPY 8.2 billion investment in production upgrades and share subscription rights issuance to enhance operational capacity and align with its strategic goals of maximizing production and sales. Navigate through the intricacies of Lifedrink Company with our comprehensive analyst estimates report here. Our valuation report unveils the possibility Lifedrink Company's shares may be trading at a premium. Turning Ideas Into Actions Reveal the 587 hidden gems among our Fast Growing Asian Companies With High Insider Ownership screener with a single click here. Contemplating Other Strategies? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include SZSE:002706 SZSE:300353 and TSE:2585. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
22-05-2025
- Business
- Yahoo
Asian Growth Stocks With Significant Insider Ownership
As global markets react positively to the recent de-escalation in U.S.-China trade tensions, Asian stocks are seeing renewed interest from investors looking for growth opportunities. In this environment, companies with high insider ownership often stand out as they may indicate confidence from those who know the business best. Name Insider Ownership Earnings Growth Sineng ElectricLtd (SZSE:300827) 36% 26.9% Schooinc (TSE:264A) 26.6% 68.9% Nanya New Material TechnologyLtd (SHSE:688519) 11% 63.3% Global Tax Free (KOSDAQ:A204620) 20.8% 35.1% Oscotec (KOSDAQ:A039200) 21.1% 94.4% Fulin Precision (SZSE:300432) 13.6% 44.2% M31 Technology (TPEX:6643) 30.8% 63.4% Zhejiang Leapmotor Technology (SEHK:9863) 15.6% 60% Vuno (KOSDAQ:A338220) 15.6% 109.8% Techwing (KOSDAQ:A089030) 18.8% 68% Click here to see the full list of 621 stocks from our Fast Growing Asian Companies With High Insider Ownership screener. Underneath we present a selection of stocks filtered out by our screen. Simply Wall St Growth Rating: ★★★★★☆ Overview: CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China, with a market cap of HK$12.06 billion. Operations: The company generates revenue from its vaccine product research and development for human use, amounting to CN¥869.22 million. Insider Ownership: 31.4% CanSino Biologics is poised for significant growth, with earnings forecasted to increase by 158.69% annually and revenue expected to grow at 30.7% per year, surpassing the Hong Kong market average. Despite trading well below its estimated fair value, the company's return on equity is projected to remain low at 9.1%. Recent developments include a Phase I trial approval in Indonesia for an innovative inhaled tuberculosis vaccine and a strategic collaboration in Saudi Arabia for vaccine commercialization, enhancing its global footprint. Take a closer look at CanSino Biologics' potential here in our earnings growth report. Our comprehensive valuation report raises the possibility that CanSino Biologics is priced lower than what may be justified by its financials. Simply Wall St Growth Rating: ★★★★★☆ Overview: OSL Group Limited is an investment holding company that operates in the digital assets and blockchain platform sector across Hong Kong, Australia, Japan, Singapore, and Mainland China with a market cap of HK$7.90 billion. Operations: The company generates revenue of HK$374.75 million from its digital assets and blockchain platform business across several key markets, including Hong Kong, Australia, Japan, Singapore, and Mainland China. Insider Ownership: 33.8% OSL Group is set for robust growth, with revenue projected to rise by 32.5% annually, outpacing the Hong Kong market. Earnings are expected to increase significantly at 60% per year. The company recently launched OSL Wealth, a platform for managing crypto assets, leveraging Hong Kong's financial hub status. Despite becoming profitable this year with sales reaching HK$374.75 million and net income of HK$47.65 million, its future return on equity remains modest at 19.6%. Click here to discover the nuances of OSL Group with our detailed analytical future growth report. The valuation report we've compiled suggests that OSL Group's current price could be inflated. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Suzhou Dongshan Precision Manufacturing Co., Ltd. operates in the precision manufacturing industry with a market cap of CN¥50.03 billion. Operations: The company generates revenue from various segments in the precision manufacturing industry, with total revenues detailed in millions of CN¥. Insider Ownership: 28.6% Suzhou Dongshan Precision Manufacturing's recent buyback of 4.2 million shares for CNY 100.08 million highlights its commitment to shareholder value, though insider ownership details over the past three months are unavailable. Despite a volatile share price and profit margins declining from 5.1% to 3.3%, earnings are forecasted to grow significantly at 36.5% annually, surpassing market expectations, while revenue growth is projected at a slower pace of 14.2%. Click to explore a detailed breakdown of our findings in Suzhou Dongshan Precision Manufacturing's earnings growth report. Our valuation report unveils the possibility Suzhou Dongshan Precision Manufacturing's shares may be trading at a discount. Click this link to deep-dive into the 621 companies within our Fast Growing Asian Companies With High Insider Ownership screener. Ready To Venture Into Other Investment Styles? Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include SEHK:6185 SEHK:863 and SZSE:002384. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
21-05-2025
- Business
- Yahoo
Asian Growth Companies With High Insider Ownership May 2025
As the global market responds positively to the recent U.S.-China tariff pause, Asian markets are experiencing a renewed sense of optimism, with stock indices showing signs of recovery. In this environment, growth companies with high insider ownership in Asia present intriguing opportunities for investors seeking alignment between management and shareholder interests. Name Insider Ownership Earnings Growth Sineng ElectricLtd (SZSE:300827) 36% 26.9% Schooinc (TSE:264A) 26.6% 68.9% Nanya New Material TechnologyLtd (SHSE:688519) 11% 63.3% Global Tax Free (KOSDAQ:A204620) 20.8% 35.1% Oscotec (KOSDAQ:A039200) 21.1% 94.4% Fulin Precision (SZSE:300432) 13.6% 44.2% Zhejiang Leapmotor Technology (SEHK:9863) 15.6% 60% giftee (TSE:4449) 34.5% 63.7% Suzhou Sunmun Technology (SZSE:300522) 35.4% 77.7% Techwing (KOSDAQ:A089030) 18.8% 68% Click here to see the full list of 621 stocks from our Fast Growing Asian Companies With High Insider Ownership screener. Let's explore several standout options from the results in the screener. Simply Wall St Growth Rating: ★★★★★★ Overview: APT Medical Inc. focuses on the research, development, manufacturing, and supply of electrophysiology and vascular interventional medical devices in China with a market cap of CN¥40.76 billion. Operations: The company's revenue segment consists of medical products, generating CN¥2.17 billion. Insider Ownership: 22% Revenue Growth Forecast: 25.6% p.a. APT Medical's earnings grew by 25.4% last year, with future earnings expected to grow significantly at 26.6% per year, outpacing the CN market's projected growth. Revenue is also forecast to increase rapidly at 25.6% annually. The company trades at a substantial discount of 44.5% below its estimated fair value and boasts a high forecasted Return on Equity of 28.8%. Recent quarterly results show strong performance with sales reaching CNY 564.28 million, up from CNY 455.33 million the previous year, and net income rising to CNY 183.15 million from CNY 140.14 million. Click to explore a detailed breakdown of our findings in APT Medical's earnings growth report. In light of our recent valuation report, it seems possible that APT Medical is trading behind its estimated value. Simply Wall St Growth Rating: ★★★★★☆ Overview: Anhui Huaheng Biotechnology Co., Ltd. is involved in the development, production, and sale of amino acids and other organic acids both in China and internationally, with a market cap of CN¥7.87 billion. Operations: The company's revenue is primarily derived from its Bio Manufacturing Industry segment, amounting to CN¥2.36 billion. Insider Ownership: 30.1% Revenue Growth Forecast: 21% p.a. Anhui Huaheng Biotechnology is poised for significant growth, with earnings projected to increase by over 42% annually, surpassing the Chinese market's average. Revenue is also expected to grow at a robust 21% per year. However, recent financials show a decline in net income from CNY 86.57 million to CNY 51.1 million year-over-year despite sales rising to CNY 687.06 million from CNY 500.78 million, indicating challenges in maintaining profit margins amidst expansion efforts. Get an in-depth perspective on Anhui Huaheng Biotechnology's performance by reading our analyst estimates report here. According our valuation report, there's an indication that Anhui Huaheng Biotechnology's share price might be on the expensive side. Simply Wall St Growth Rating: ★★★★★☆ Overview: Shenzhen Noposion Crop Science Co., Ltd. engages in the research, development, production, and sale of agricultural inputs both in China and internationally, with a market cap of CN¥10.58 billion. Operations: The company's revenue is primarily derived from the research, development, production, and sale of agricultural inputs both domestically and internationally. Insider Ownership: 29.6% Revenue Growth Forecast: 14.9% p.a. Shenzhen Noposion Crop Science demonstrates promising growth potential, with earnings expected to rise significantly at 25.1% annually, outpacing the Chinese market. Despite high debt levels and a dividend yield of 3.28% not fully covered by free cash flows, its revenue is forecast to grow faster than the market average. Recent financials reveal strong performance with Q1 2025 net income increasing to CNY 626.93 million from CNY 454.31 million year-over-year, indicating robust operational growth despite financial constraints. Click here and access our complete growth analysis report to understand the dynamics of Shenzhen Noposion Crop Science. Our comprehensive valuation report raises the possibility that Shenzhen Noposion Crop Science is priced lower than what may be justified by its financials. Unlock more gems! Our Fast Growing Asian Companies With High Insider Ownership screener has unearthed 618 more companies for you to here to unveil our expertly curated list of 621 Fast Growing Asian Companies With High Insider Ownership. Seeking Other Investments? Trump's oil boom is here — pipelines are primed to profit. Discover the 22 US stocks riding the wave. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include SHSE:688617 SHSE:688639 and SZSE:002215. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19-05-2025
- Business
- Yahoo
Asian Growth Companies With High Insider Ownership
As the global markets react positively to the recent U.S.-China tariff suspension, Asian equities have shown resilience with Chinese stocks rallying on hopes of reduced trade tensions. In such a climate, identifying growth companies with substantial insider ownership can be particularly appealing, as high insider stakes often signal confidence in a company's future prospects and alignment with shareholder interests. Name Insider Ownership Earnings Growth Sineng ElectricLtd (SZSE:300827) 36% 26.8% Nanya New Material TechnologyLtd (SHSE:688519) 11% 63.1% Schooinc (TSE:264A) 26.6% 68.9% Global Tax Free (KOSDAQ:A204620) 20.8% 35.1% Fulin Precision (SZSE:300432) 13.6% 44.2% Oscotec (KOSDAQ:A039200) 21.1% 85.9% Zhejiang Leapmotor Technology (SEHK:9863) 15.6% 60.7% giftee (TSE:4449) 34.5% 63.7% Suzhou Sunmun Technology (SZSE:300522) 35.4% 77.7% Techwing (KOSDAQ:A089030) 18.8% 65% Click here to see the full list of 619 stocks from our Fast Growing Asian Companies With High Insider Ownership screener. We're going to check out a few of the best picks from our screener tool. Simply Wall St Growth Rating: ★★★★☆☆ Overview: MIXUE Group operates in the production and sale of fruit drinks, tea drinks, ice cream, and coffee products both in Mainland China and internationally, with a market cap of HK$195.69 billion. Operations: The company's revenue is primarily derived from franchise and related services (CN¥620.05 million), sales of goods (CN¥23.45 billion), and sales of equipment (CN¥756.37 million). Insider Ownership: 28.8% MIXUE Group, recently completing an HKD 3.45 billion IPO, demonstrates strong growth potential with earnings forecasted to grow at 16.1% annually, outpacing the Hong Kong market's average. Despite high share price volatility and moderate revenue growth projections of 13.4%, the company's high insider ownership aligns interests with shareholders. Recent changes in share capital structure following a full exercise of the over-allotment option reflect strategic adjustments post-IPO to support its expansion ambitions in Asia. Click to explore a detailed breakdown of our findings in MIXUE Group's earnings growth report. Upon reviewing our latest valuation report, MIXUE Group's share price might be too optimistic. Simply Wall St Growth Rating: ★★★★★★ Overview: Akeso, Inc., a biopharmaceutical company, focuses on the research, development, manufacturing, and commercialization of antibody drugs with a market cap of approximately HK$74.99 billion. Operations: The company's revenue is primarily derived from the research, development, production, and sale of biopharmaceutical products, totaling CN¥2.12 billion. Insider Ownership: 19% Akeso's high insider ownership aligns with its growth trajectory, as the company is trading at a significant discount to its estimated fair value. Akeso's revenue is expected to grow rapidly at 29.6% annually, outpacing the Hong Kong market average. The company's recent approval of ivonescimab for NSCLC treatment and FDA approval of penpulimab highlight strong innovation capabilities despite recent earnings decline, positioning Akeso for potential profitability and robust market presence in oncology therapeutics. Navigate through the intricacies of Akeso with our comprehensive analyst estimates report here. According our valuation report, there's an indication that Akeso's share price might be on the expensive side. Simply Wall St Growth Rating: ★★★★★☆ Overview: InnoCare Pharma Limited is a biopharmaceutical company focused on discovering, developing, and commercializing drugs for cancer and autoimmune diseases in China, with a market cap of HK$21.34 billion. Operations: The company's revenue is primarily derived from its pharmaceuticals segment, totaling CN¥1.01 billion. Insider Ownership: 21.4% InnoCare Pharma benefits from high insider ownership, supporting its rapid growth trajectory with revenue expected to increase by 23.7% annually, surpassing the Hong Kong market average. The company is advancing several promising therapies, including Soficitinib for vitiligo and Mesutoclax for lymphoma, both receiving regulatory recognition in China. Despite current unprofitability and past losses of C¥440.63 million, InnoCare trades below estimated fair value, driven by a strong pipeline and potential future profitability in the biotech sector. Delve into the full analysis future growth report here for a deeper understanding of InnoCare Pharma. The valuation report we've compiled suggests that InnoCare Pharma's current price could be inflated. Embark on your investment journey to our 619 Fast Growing Asian Companies With High Insider Ownership selection here. Ready For A Different Approach? AI is about to change healthcare. These 21 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include SEHK:2097 SEHK:9926 and SEHK:9969. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
